Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

HDAC inhibitors help brain cells grow and improve brain function.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Repurposing existing drugs can improve cancer treatment but faces challenges.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Vitamin D receptor helps prevent skin tumors.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Metal binding to sodium valproate may be linked to hair loss in epilepsy patients.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Pantethine may boost the immune system's ability to fight sarcoma.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Disrupted citric acid metabolism stops hair growth.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.